Gamble Jones Investment Counsel Merck & Co., Inc. Transaction History

Gamble Jones Investment Counsel

$1.33 Billion
Q4 2022

A detailed history of Gamble Jones Investment Counsel transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gamble Jones Investment Counsel holds 9,683 shares of MRK stock, worth $778,803. This represents 0.08% of its overall portfolio holdings.

Number of Shares

9,683

Previous 9,683 -0.0%

Holding current value

$778,803

Previous $834,000 28.78%

% of portfolio

0.08%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$84.53 - $94.96 $32,459 - $36,464	-384 Reduced 3.81%	9,683 $834,000
Q2 2022 Aug 05, 2022	SELL	$83.49 - $94.64 $116,886 - $132,496	-1,400 Reduced 12.21%	10,067 $918,000
Q1 2022 May 02, 2022	SELL	$73.51 - $82.4 $97,915 - $109,756	-1,332 Reduced 10.41%	11,467 $941,000
Q3 2021 Nov 09, 2021	SELL	$71.68 - $78.83 $64,512 - $70,947	-900 Reduced 6.57%	12,799 $961,000
Q2 2021 Aug 06, 2021	SELL	$70.31 - $77.77 $17,929 - $19,831	-255 Reduced 1.83%	13,699 $1.07 Million
Q1 2021 May 10, 2021	SELL	$68.86 - $81.11 $100,053 - $117,852	-1,453 Reduced 9.43%	13,954 $1.08 Million
Q4 2020 Feb 10, 2021	SELL	$71.77 - $79.65 $44,712 - $49,621	-623 Reduced 3.89%	15,407 $1.26 Million
Q3 2020 Nov 10, 2020	SELL	$73.18 - $82.95 $69,447 - $78,719	-949 Reduced 5.59%	16,030 $1.33 Million
Q2 2020 Aug 19, 2020	SELL	$70.42 - $80.13 $35,914 - $40,866	-510 Reduced 2.92%	16,979 $1.31 Million
Q1 2020 May 08, 2020	SELL	$63.36 - $87.82 $22,176 - $30,736	-350 Reduced 1.96%	17,489 $1.35 Million
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $1,629 - $1,838	21 Added 0.12%	17,839 $1.62 Million
Q3 2019 Nov 04, 2019	SELL	$76.08 - $82.93 $56,831 - $61,948	-747 Reduced 4.02%	17,818 $1.5 Million
Q2 2019 Aug 20, 2019	SELL	$69.84 - $81.59 $25,212 - $29,453	-361 Reduced 1.91%	18,565 $1.56 Million
Q1 2019 May 02, 2019	SELL	$69.58 - $79.36 $8,906 - $10,158	-128 Reduced 0.67%	18,926 $1.57 Million
Q3 2018 Nov 06, 2018	SELL	$57.69 - $67.84 $30,171 - $35,480	-523 Reduced 2.67%	19,054 $1.35 Million
Q2 2018 Aug 03, 2018	SELL	$50.83 - $59.72 $38,122 - $44,790	-750 Reduced 3.69%	19,577 $1.19 Million
Q1 2018 May 10, 2018	SELL	$50.96 - $59.23 $16,969 - $19,723	-333 Reduced 1.61%	20,327 $1.11 Million
Q4 2017 Feb 06, 2018	BUY	$51.62 - $61.64 $103 - $123	2 Added 0.01%	20,660 $1.16 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $1.21 Million - $1.3 Million	20,658	20,658 $1.32 Million

Others Institutions Holding MRK

# of Institutions

3,889

Shares Held

1.88B

Call Options Held

16.9M

Put Options Held

14.9M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $204B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamble Jones Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Gamble Jones Investment Counsel with notifications on news.

Account

Gamble Jones Investment Counsel Merck & Co., Inc. Transaction History